Garuda Therapeutics
在场
高管
查看带有其 14 名主要高管的组织结构图
Garuda Therapeutics 搜索最多的简介
- Dhvanit Shah, Director, President and Chief Executive Officer
- Raymond Kelleher, Director
- Rahul Singhvi, Director
高管在Garuda Therapeutics变化
- Panteli Theocharous已作为Chief Therapeutics Officer加入公司 (新闻发布的2023十月26号).
创建提醒
跟踪 Garuda Therapeutics 的高管变动
生物技术
Garuda Therapeutics 拥有 2,282 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Endeavor BioMedicines 刚刚宣布为 132 筹款数百万美元。 (公布2024四月25号).
- Metsera 刚刚宣布为 290 筹款数百万美元。 (公布2024四月23号).
- Histogen has filed for bankruptcy protection (公布2024四月19号).
生物技术 行业的其他推荐联系人
消息
Garuda Therapeutics 的最新新闻稿
- Garuda Therapeutics Named “Overall Cell Biology Company of the Year” By BioTech Breakthrough
- Garuda Therapeutics Announces the Appointment of Giorgia Scapin, Ph.D., as Chief Scientific Officer
- Be The Match BioTherapies® To Provide Robust Cell Therapy Infrastructure to Support Garuda Therapeutics’ Potentially Ground-Breaking Off-The-Shelf Cell Therapies
- Garuda Therapeutics Secures $62 Million Series B Financing to Advance Off-the-Shelf Blood Stem Cell Technology Platform
- Garuda Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
- Garuda Therapeutics Announces Appointment of David DiGiusto, Ph.D., as Chief Technology Officer
- Garuda Therapeutics Announces Appointment of Roger Sawhney, M.D., as Chief Financial Officer
- Garuda Therapeutics Announces Appointment of James Desiderio as Chief Regulatory Officer
- View more press releases Close
通过电子邮件
